Idelalisib in the management of lymphoma von Cheah, Chan Yoon, Fowler, Nathan H.

Volltext

Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma von Gribben, John G, Fowler, Nathan, Morschhauser, Franck

Volltext

AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma von Leonard, John P, Trneny, Marek, Izutsu, Koji, Fowler, Nathan H, Hong, Xiaonan, Zhu, Jun, Zhang, Huilai, Offner, Fritz, Scheliga, Adriana, Nowakowski, Grzegorz S, Pinto, Antonio, Re, Francesca, Fogliatto, Laura Maria, Scheinberg, Phillip, Flinn, Ian W, Moreira, Claudia, Cabeçadas, José, Liu, David, Kalambakas, Stacey, Fustier, Pierre, Wu, Chengqing, Gribben, John G

Volltext

Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies von ADVANI, Ranjana H, BUGGY, Joseph J, SUKBUNTHERNG, Juthamas, IZUMI, Raquel, HAMDY, Ahmed, HEDRICK, Eric, FOWLER, Nathan H, SHARMAN, Jeff P, SMITH, Sonali M, BOYD, Thomas E, GRANT, Barbara, KOLIBABA, Kathryn S, FURMAN, Richard R, RODRIGUEZ, Sara, CHANG, Betty Y

Volltext

Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma von Strati, Paolo, Varma, Ankur, Adkins, Sherry, Nastoupil, Loretta J., Westin, Jason R., Hagemeister, Fredrick B., Fowler, Nathan H., Lee, Hun J., Fayad, Luis E., Samaniego, Felipe, Ahmed, Sairah, Chen, Yiming, Horowitz, Sandra, Arafat, Sara, Johncy, Swapna, Kebriaei, Partow, Mulanovich, Victor Eduardo, Heredia, Ella Ariza, Neelapu, Sattva S.

Volltext

Ibrutinib and Venetoclax for First-Line Treatment of CLL von Jain, Nitin, Keating, Michael, Thompson, Philip, Ferrajoli, Alessandra, Burger, Jan, Borthakur, Gautam, Takahashi, Koichi, Estrov, Zeev, Fowler, Nathan, Kadia, Tapan, Konopleva, Marina, Alvarado, Yesid, Yilmaz, Musa, DiNardo, Courtney, Bose, Prithviraj, Ohanian, Maro, Pemmaraju, Naveen, Jabbour, Elias, Sasaki, Koji, Kanagal-Shamanna, Rashmi, Patel, Keyur, Jorgensen, Jeffrey, Garg, Naveen, Wang, Xuemei, Sondermann, Katrina, Cruz, Nichole, Wei, Chongjuan, Ayala, Ana, Plunkett, William, Kantarjian, Hagop, Gandhi, Varsha, Wierda, William

Volltext

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma von Morschhauser, Franck, Fowler, Nathan H, Feugier, Pierre, Bouabdallah, Reda, Tilly, Hervé, Palomba, M. Lia, Fruchart, Christophe, Libby, Edward N, Casasnovas, Rene-Olivier, Flinn, Ian W, Haioun, Corinne, Maisonneuve, Hervé, Ysebaert, Loic, Bartlett, Nancy L, Bouabdallah, Kamal, Brice, Pauline, Ribrag, Vincent, Daguindau, Nicolas, Le Gouill, Steven, Pica, Gian M, Martin Garcia-Sancho, Alejandro, López-Guillermo, Armando, Larouche, Jean-François, Ando, Kiyoshi, Gomes da Silva, Maria, André, Marc, Zachée, Pierre, Sehn, Laurie H, Tobinai, Kensei, Cartron, Guillaume, Liu, David, Wang, Jianming, Xerri, Luc, Salles, Gilles A

Volltext

Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial von Fowler, Nathan H, Dr, Davis, R Eric, MD, Rawal, Seema, PhD, Nastoupil, Loretta, MD, Hagemeister, Fredrick B, Prof, McLaughlin, Peter, Prof, Kwak, Larry W, Prof, Romaguera, Jorge E, Prof, Fanale, Michelle A, MD, Fayad, Luis E, MD, Westin, Jason R, MD, Shah, Jatin, MD, Orlowski, Robert Z, Prof, Wang, Michael, Prof, Turturro, Francesco, Prof, Oki, Yasuhiro, MD, Claret, Linda C, RN, Feng, Lei, MS, Baladandayuthapani, Veerabhadran, PhD, Muzzafar, Tariq, MD, Tsai, Kenneth Y, MD, Samaniego, Felipe, MD, Neelapu, Sattva S, MD

Volltext

Lenalidomide in follicular lymphoma von Flowers, Christopher R., Leonard, John P., Fowler, Nathan H.

Volltext

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma von Wilson, Wyndham H, Young, Ryan M, Schmitz, Roland, Yang, Yandan, Pittaluga, Stefania, Wright, George, Lih, Chih-Jian, Williams, P Mickey, Shaffer, Arthur L, Gerecitano, John, de Vos, Sven, Goy, Andre, Kenkre, Vaishalee P, Barr, Paul M, Blum, Kristie A, Shustov, Andrei, Advani, Ranjana, Fowler, Nathan H, Vose, Julie M, Elstrom, Rebecca L, Habermann, Thomas M, Barrientos, Jacqueline C, McGreivy, Jesse, Fardis, Maria, Chang, Betty Y, Clow, Fong, Munneke, Brian, Moussa, Davina, Beaupre, Darrin M, Staudt, Louis M

Volltext

Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma von Ma, Man Chun John, Tadros, Saber, Bouska, Alyssa, Heavican, Tayla, Yang, Haopeng, Deng, Qing, Moore, Dalia, Akhter, Ariz, Hartert, Keenan, Jain, Neeraj, Showell, Jordan, Ghosh, Sreejoyee, Street, Lesley, Davidson, Marta, Carey, Christopher, Tobin, Joshua, Perumal, Deepak, Vose, Julie M, Lunning, Matthew A, Sohani, Aliyah R, Chen, Benjamin J, Buckley, Shannon, Nastoupil, Loretta J, Davis, R Eric, Westin, Jason R, Fowler, Nathan H, Parekh, Samir, Gandhi, Maher, Neelapu, Sattva, Stewart, Douglas, Bhalla, Kapil, Iqbal, Javeed, Greiner, Timothy, Rodig, Scott J, Mansoor, Adnan, Green, Michael R

Volltext

Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures von Kotlov, Nikita, Bagaev, Alexander, Revuelta, Maria, Phillip, Jude M., Cacciapuoti, Maria Teresa, Antysheva, Zoya, Svekolkin, Viktor, Tikhonova, Ekaterina, Miheecheva, Natalia, Kuzkina, Natalia, Nos, Grigorii, Tabbo, Fabrizio, Frenkel, Felix, Ghione, Paola, Tsiper, Maria, Almog, Nava, Fowler, Nathan, Melnick, Ari M., Leonard, John P., Inghirami, Giorgio, Cerchietti, Leandro

Volltext

Novel agents for relapsed and refractory follicular lymphoma von Cheah, Chan Yoon, Fowler, Nathan H.

Volltext

Umbralisib, a Dual PI3K delta/CK1 epsilon Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma von Fowler, Nathan H., Samaniego, Felipe, Jurczak, Wojciech, Ghosh, Nilanjan, Derenzini, Enrico, Reeves, James A., Knopinska-Posluszny, Wanda, Cheah, Chan Y., Phillips, Tycel, Lech-Maranda, Ewa, Cheson, Bruce D., Caimi, Paolo F., Grosicki, Sebastian, Leslie, Lori A., Chavez, Julio C., Fonseca, Gustavo, Babu, Sunil, Hodson, Daniel J., Shao, Spencer H., Burke, John M., Sharman, Jeff P., Law, Jennie Y., Pagel, John M., Miskin, Hari P., Sportelli, Peter, O'Connor, Owen A., Weiss, Michael S., Zinzani, Pier Luigi

Volltext

Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label,... von Sehn, Laurie H, Dr, Chua, Neil, MD, Mayer, Jiri, Prof, Dueck, Gregg, MD, Trněný, Marek, Prof, Bouabdallah, Kamal, MD, Fowler, Nathan, MD, Delwail, Vincent, MD, Press, Oliver, Prof, Salles, Gilles, MD, Gribben, John, Prof, Lennard, Anne, MBBS, Lugtenburg, Pieternella J, MD, Dimier, Natalie, MSc, Wassner-Fritsch, Elisabeth, PharmD, Fingerle-Rowson, Günter, MD, Cheson, Bruce D, Prof

Volltext

Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial von Westin, Jason R, MD, Chu, Fuliang, PhD, Zhang, Min, PhD, Fayad, Luis E, MD, Kwak, Larry W, Prof, Fowler, Nathan, MD, Romaguera, Jorge, Prof, Hagemeister, Fredrick, Prof, Fanale, Michelle, MD, Samaniego, Felipe, MD, Feng, Lei, MS, Baladandayuthapani, Veerabhadran, PhD, Wang, Zhiqiang, PhD, Ma, Wencai, PhD, Gao, Yanli, MS, Wallace, Michael, Prof, Vence, Luis M, PhD, Radvanyi, Laszlo, Prof, Muzzafar, Tariq, MD, Rotem-Yehudar, Rinat, PhD, Davis, R Eric, MD, Neelapu, Sattva S, Dr

Volltext

The risk of central nervous system relapses in patients with peripheral T-cell lymphoma von Chihara, Dai, Fanale, Michelle A, Miranda, Roberto N, Noorani, Mansoor, Westin, Jason R, Nastoupil, Loretta J, Hagemeister, Fredrick B, Fayad, Luis E, Romaguera, Jorge E, Samaniego, Felipe, Turturro, Francesco, Lee, Hun J, Neelapu, Sattva S, Rodriguez, M Alma, Wang, Michael, Fowler, Nathan H, Davis, Richard E, Medeiros, L Jeffrey, Oki, Yasuhiro

Volltext

Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/refractory indolent lymphoma von Cheah, Chan Yoon, Nastoupil, Loretta J., Neelapu, Sattva S., Forbes, Sheryl G., Oki, Yasuhiro, Fowler, Nathan H.

Volltext

Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes von Zaitsev, Aleksandr, Chelushkin, Maksim, Dyikanov, Daniiar, Cheremushkin, Ilya, Shpak, Boris, Nomie, Krystle, Zyrin, Vladimir, Nuzhdina, Ekaterina, Lozinsky, Yaroslav, Zotova, Anastasia, Degryse, Sandrine, Kotlov, Nikita, Baisangurov, Artur, Shatsky, Vladimir, Afenteva, Daria, Kuznetsov, Alexander, Paul, Susan Raju, Davies, Diane L., Reeves, Patrick M., Lanuti, Michael, Goldberg, Michael F., Tazearslan, Cagdas, Chasse, Madison, Wang, Iris, Abdou, Mary, Aslanian, Sharon M., Andrewes, Samuel, Hsieh, James J., Ramachandran, Akshaya, Lyu, Yang, Galkin, Ilia, Svekolkin, Viktor, Cerchietti, Leandro, Poznansky, Mark C., Ataullakhanov, Ravshan, Fowler, Nathan, Bagaev, Alexander

Volltext

Double hit lymphoma: the MD Anderson Cancer Center clinical experience von Oki, Yasuhiro, Noorani, Mansoor, Lin, Pei, Davis, Richard E., Neelapu, Sattva S., Ma, Long, Ahmed, Mohamed, Rodriguez, Maria Alma, Hagemeister, Fredrick B., Fowler, Nathan, Wang, Michael, Fanale, Michelle A., Nastoupil, Loretta, Samaniego, Felipe, Lee, Hun J., Dabaja, Bouthaina S., Pinnix, Chelsea C., Medeiros, Leonard J., Nieto, Yago, Khouri, Issa, Kwak, Larry W., Turturro, Francesco, Romaguera, Jorge E., Fayad, Luis E., Westin, Jason R.

Volltext